Evidence map›Paper›PMID 26239729›Full record

ArticleIntensive care medicine2015

Gain-of-function single nucleotide variants of the CYP2C19 gene (CYP2C19*17) can identify subtherapeutic voriconazole concentrations in critically ill patients: a case series.

Joachim D Weigel, Nicole G M Hunfeld, Birgit C P Koch, Mohamud Egal, Jan Bakker, Ron H N van Schaik, Teun van Gelder

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joachim D WeigelDepartment of Intensive Care Medicine, Erasmus Medical Center, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. j.weigel@erasmusmc.nl.
Nicole G M HunfeldDepartment of Intensive Care Medicine, Erasmus Medical Center, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
Birgit C P KochDepartment of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
Mohamud EgalDepartment of Intensive Care Medicine, Erasmus Medical Center, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
Jan BakkerDepartment of Intensive Care Medicine, Erasmus Medical Center, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
Ron H N van SchaikDepartment of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.
Teun van GelderDepartment of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsAspergillosisCritical IllnessCytochrome P-450 CYP2C19GenotypeHumansPhenotypePolymorphism, Single NucleotideRetrospective StudiesVoriconazoleAntifungal AgentsCYP2C19 protein, humanCytochrome P-450 CYP2C19Voriconazole

Identifiers

PMID26239729
OpenAlexW1094466985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.